Download PDF
Horm Metab Res 2011; 43(8): 557-561
DOI: 10.1055/s-0031-1275706
Humans, Clinical

© Georg Thieme Verlag KG Stuttgart · New York

Genetic Variation in Macrophage Migration Inhibitory Factor Associated with Gestational Diabetes Mellitus and Metabolic Syndrome

S. Aslani1 , A. Hossein-nezhad1 , Z. Maghbooli1 , K. Mirzaei1 , F. Karimi1
  • 1Endocrinology & Metabolism Research Centre, Tehran University of Medical Sciences, Tehran, Iran
Further Information

Publication History

received 15.09.2010

accepted 23.03.2011

Publication Date:
21 April 2011 (online)

Also available at
    Permissions and Reprints

Abstract

The aim of this study was to investigate the association of macrophage migration inhibitory factor (MIF) polymorphism rs1007888 with gestational diabetes mellitus (GDM), and its association with postpartum metabolic syndrome. In a case-control study, 147 GDM and 169 healthy pregnant patients were recruited. Blood sample was taken 2 times from all the participants; one at 24–28 weeks of gestation, second at 6–12 weeks of postpartum. Biochemical measurement and DNA extraction were performed. The PCR_SSP was performed for genotyping. The frequencies of AA, AG, and GG genotypes were 11.24% (19), 76.92% (130), and 11.83% (20) in healthy pregnancies and were 7.48% (11), 70.74% (104), and 21.76% (32) in GDM individuals. The distributions of MIF genotypes were significantly different in GDM and healthy subjects (p=0.04). Moreover, GG genotype had a significant association with pre-pregnancy obesity and family history of diabetes. In postpartum follow-up GG genotype was two-fold more frequent in women with metabolic syndrome (p=0.01, odds ratio=2.30, CI 95%; 1.23–4.30) and relative risk was equal 1.77 (CI 95%; 1.19–2.64). Our findings demonstrate an association between MIF polymorphism rs1007888 and susceptibility to GDM in pregnancy and metabolic syndrome development.

Key words

GDM - metabolic syndrome - MIF - rs1007888 - polymorphism

References

  • 1 Hossein-nezhad A, Mirzaei K, Maghbooli Z, Larijani B. Maternal glycemic status in GDM patients after delivery.  Iranian J Diabetes Lipid Disorders. 2009;  95-104
    Search in Google Scholar
  • 2 Hossein-Nezhad A, Maghbooli Z, Vassigh ABL. Prevalence of gestational diabetes mellitus and pregnancy outcomes in Iranian women.  Taiwan J Obstet Gynecol. 2007;  46 236-241
    Search in Google Scholar
  • 3 Maghbooli Z, Hossein-nezhad A, Karimi F, Shafaei A, Larijani B. Correlation between vitamin D3 deficiency and insulin resistance in pregnancy.  Diabetes Metab Res Rev. 2008;  24 27-32
    Search in Google Scholar
  • 4 González-Clementea JM, Carroa O, Gallacha I, Vioqueb J, Humanesa A, Saureta C, Abella M, Giménez-Pérez G, Mauricio D. Increased cholesterol intake in women with gestational diabetes mellitus.  Diabetes Metab. 2007;  33 25-29
    Search in Google Scholar
  • 5 Enquobahrie D, Williams M, Qiu C, Meller M, Sorensen T. Global placental gene expression in gestational diabetes mellitus.  Am J Obstet Gynecol. 2009;  200 206-213
    Search in Google Scholar
  • 6 Martin RJSD, Carson DJ, McKnight AJ, Maxwell AP, Patterson CC. Polymorphisms of the macrophage migration inhibitory factor gene in a UK population with Type 1 diabetes mellitus.  DIABETIC Medicine. 2010;  27 143-149
    Search in Google Scholar
  • 7 Herder C, Klopp N, Baumert J, Müller M, Khuseyinova N, Meisinger C, Martin S, Illig T, Koenig W, Thorand B. Effect of macrophage migration inhibitory factor (MIF) gene variants and MIF serum concentrations on the risk of type 2 diabetes: results from the MONICA/KORA Augsburg Case-Cohort Study, 1984–2002.  Diabetologia. 2008;  51 276-284
    Search in Google Scholar
  • 8 Yabunaka N, Nishihira J, Mizue Y, Tsuji M, Kumagai M, Ohtsuka Y, Imamura M, Asaka M. Elevated serum content of macrophage migration inhibitory factor in patients with type 2 diabetes.  Diabetes Care. 2002;  23 256-258
    Search in Google Scholar
  • 9 Ietta F, Wu Y, Romagnoli R, Soleymanlou N, Orsini B, Zamudio S, Paulesu L, Caniggia I. Oxygen regulation of macrophage migration inhibitory factor in human placenta.  Am J Physiol Endocrinol Metab. 2007;  292 272-280
    Search in Google Scholar
  • 10 Toso C, Emamaullee J, Merani S, Shapiro A. The role of macrophage migration inhibitory factor on glucose metabolism and diabetes.  Diabetologia. 2008;  51 1937-1946
    Search in Google Scholar
  • 11 Kleemann R, Bucala R. Macrophage migration inhibitory factor: critical role in obesity, insulin resistance, and associated comorbidities.  Mediators Inflam. 2010;  2010 610479
    Search in Google Scholar
  • 12 Calandra T, Bernhagen J, Mitchell R, Bucala R. The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor.  J Exp Med. 1994;  179 1895-1902
    Search in Google Scholar
  • 13 Waeber G, Calandra T, Roduit R, Haefliger J, Bonny C, Thompson N, Thorens B, Temler E, Meinhardt A, Bacher M, Metz CN, Nicod P, Bucala R. Insulin secretion is regulated by the glucose-dependent production of islet beta cell macrophage migration inhibitory factor.  Proc Natl Acad Sci USA. 1997;  94 4782-4787
    Search in Google Scholar
  • 14 Herder C, Illig T, Baumert J, Müller M, Klopp N, Khuseyinova N, Meisinger C, Martin S, Thorand B, Koenig W. Macrophage migration inhibitory factor (MIF) and risk for coronary heart disease: results from the MONICA/KORA Augsburg case-cohort study, 1984–2002.  Atherosclerosis. 2008;  200 380-388
    Search in Google Scholar
  • 15 Tereshchenko I, Petrkova J, Mrazek F, Lukl J, Maksimov V, Romaschenko A, Voevoda MI, Petrek M. The macrophage migration inhibitory factor (MIF) gene polymorphism in Czech and Russian patients with myocardial infarction.  Clin Chim Acta. 2009;  402 199-202
    Search in Google Scholar
  • 16 Bunce M, O’Neill C, Barnardo C, Krausa P, Browning M, Morris P, Welsh KI. Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP).  Tissue Antigens. 1995;  46 355-367
    Search in Google Scholar
  • 17 Jovanovic L, Pettitt DJ. Gestational diabetes mellitus.  JAMA. 2001;  286 2516-2518
    Search in Google Scholar
  • 18 Maghbooli Z, Hossein-nezhad A, Rahmani M, Shafaei A-R, Larijani B. Relationship between leptin concentration and insulin resistance.  Horm Metab Res. 2007;  39 903-907
    Search in Google Scholar
  • 19 Butte N. Carbohydrate and lipid metabolism in pregnancy: normal compared with gestational diabetes mellitus.  Am J Clin Nutr. 2000;  71 (S 05) 1256-1261
    Search in Google Scholar
  • 20 Buchanan TA, Xiang AH. Gestational diabetes mellitus.  J Clin Invest. 2005;  115 485-491
    Search in Google Scholar
  • 21 Arcuri F, Cintorino M, Vatti R, Carducci A, Liberatori S, Paulesu L. Expression of macrophage migration inhibitory factor transcript and protein by first-trimester human trophoblasts.  Biol Reprod. 1999;  60 1299-1303
    Search in Google Scholar
  • 22 Ietta F, Todros T, Ticconi C, Piccoli E, Zicari A, Piccione E, Paulesu L. Macrophage migration inhibitory factor in human pregnancy and labor.  Am J Reprod Immunol. 2002;  48 404-409
    Search in Google Scholar
  • 23 Shiroeda H, Tahara T, Nakamura M, Shibata T, Nomura T, Yamada H, Hayashi R, Saito T, Yamada M, Fukuyama T, Otsuka T, Yano H, Ozaki K, Tsuchishima M, Tsutsumi M, Arisawa T. Association between functional promoter polymorphisms of macrophage migration inhibitory factor (MIF) gene and ulcerative colitis in Japan.  Cytokine. 2010;  51 173-177
    Search in Google Scholar
  • 24 Renner P, Roger T, Calandra T. Macrophage migration inhibitory factor: gene polymorphisms and susceptibility to inflammatory diseases.  Clin Infect Dis. 2005;  41 (S 07) S513-S519
    Search in Google Scholar
  • 25 Church T, Willis M, Priest E, Lamonte M, Earnest C, Wilkinson W, Wilson DA, Giroir BP. Obesity, macrophage migration inhibitory factor, and weight loss.  Int J Obes. 2005;  29 675-681
    Search in Google Scholar
  • 26 Calandra T, Roger T. Macrophage migration inhibitory factor: a regulator of innate immunity.  Nat Rev Immunol. 2003;  3 791-800
    Search in Google Scholar
  • 27 Atsumi T, Cho Y, Leng L, McDonald C, Yu T, Danton C, Hong EG, Mitchell RA, Metz C, Niwa H, Takeuchi J, Onodera S, Umino T, Yoshioka N, Koike T, Kim JK, Bucala R. The proinflammatory cytokine macrophage migration inhibitory factor regulates glucose metabolism during systemic inflammation.  J Immunol. 2007;  179 5399-5406
    Search in Google Scholar
  • 28 Dandona P, Aljada A, Ghanim H, Mohanty P, Tripathy C, Hofmeyer D, Chaudhuri A. Increased plasma concentration of macrophage migration inhibitory factor (MIF) and MIF mRNA in mononuclear cells in the obese and the suppressive action of metformin.  J Clin Endocrinol Metab. 2004;  89 5043-5047
    Search in Google Scholar
  • 29 Sakaue S, Ishimaru S, Hizawa N, Ohtsuka Y, Tsujino I, Honda T, Suzuki J, Kawakami Y, Nishihira J, Nishimura M. Promoter polymorphism in the macrophage migration inhibitory factor gene is associated with obesity.  Int J Obes (Lond). 2006;  30 238-242
    Search in Google Scholar
  • 30 Ghanim H, Aljada A, Hofmeyer D, Syed T, Mohanty P, Dandona P. Circulating mononuclear cells in the obese are in a proinflammatory state.  Circulation. 2004;  110 1564-1571
    Search in Google Scholar
  • 31 Dandona P, Aljada A, Chaudhuri A, Mohanty P, Garg R. Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation.  Circulation. 2005;  111 1448-1454
    Search in Google Scholar
  • 32 Skurk T, Herder C, Kräft I, Müller-Scholze S, Hauner H, Kolb H. Production and release of macrophage migration inhibitory factor from human adipocytes.  Endocrinology. 2005;  146 1006-1011
    Search in Google Scholar
  • 33 Xu H, Barnes G, Yang Q, Tan G, Yang D, Chou C, Sole J, Nichols A, Ross JS, Tartaglia LA, Chen H. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance.  J Clin Invest. 2003;  112 1821-1830
    Search in Google Scholar
  • 34 Maghbooli Z, Hossein-Nezhad A, Mirzaei K, Karimi F, Besharati A, Omidfar K, Larijani B. Association between retinol-binding protein 4 concentrations and gestational diabetes mellitus and risk of developing metabolic syndrome after pregnancy.  Reprod Sci. 2010;  17 196-201
    Search in Google Scholar

Correspondence

A. Hossein-nezhadMD, PhD 

Endocrinology & Metabolism

Research Centre

Tehran University of Medical

Sciences

5th Floor, Shariati Hospital

P. O. Box 14114

North Kargar St.

Tehran

Iran

Phone: +98/21/882 200 378

Fax: +98/21/880 220 052

Email: ahosseinnezhad@sina.tums.ac.ir